0001493152-24-004814.txt : 20240202
0001493152-24-004814.hdr.sgml : 20240202
20240202200012
ACCESSION NUMBER: 0001493152-24-004814
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240131
FILED AS OF DATE: 20240202
DATE AS OF CHANGE: 20240202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Berman Howard
CENTRAL INDEX KEY: 0001952986
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41583
FILM NUMBER: 24593560
MAIL ADDRESS:
STREET 1: C/O COYA THERAPEUTICS, INC.
STREET 2: 5850 SAN FELIPE ST., SUITE 500
CITY: HOUSTON
STATE: TX
ZIP: 77057
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Coya Therapeutics, Inc.
CENTRAL INDEX KEY: 0001835022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12645 MEMORIAL DR., SUITE F1 #305
CITY: HOUSTON
STATE: TX
ZIP: 77024
BUSINESS PHONE: 650.739.3939
MAIL ADDRESS:
STREET 1: 12645 MEMORIAL DR., SUITE F1 #305
CITY: HOUSTON
STATE: TX
ZIP: 77024
4
1
ownership.xml
X0508
4
2024-01-31
0
0001835022
Coya Therapeutics, Inc.
COYA
0001952986
Berman Howard
5850 SAN FELIPE ST., SUITE 500
HOUSTON
TX
77057
1
1
0
0
Chief Executive Officer
0
Stock Option (right to buy)
5.90
2024-01-31
4
A
0
189680
0.00
A
2034-01-31
Common Stock, par value $0.0001 per share
189680
189680
D
The option will vest in 36 equal monthly installments commencing February 29, 2024, subject to continuous service on each vesting date.
/s/ David Snyder, Attorney-in-Fact
2024-02-02